You are here: Industry Insights > Acquisition

News List

Catalent Completes Paragon Acquisition contractpharma
May 21, 2019
$1.2 billion deal for gene therapy leader is final.
Fulcrum acquires global rights of investigational drug losmapimod from GSK pharmaceutical-business-review
April 24, 2019
Fulcrum Therapeutics has acquired all worldwide development and commercialization rights of investigational drug losmapimod from GlaxoSmithKline (GSK).
MS Pharma ink deal for acquisition of Genepharm pharmafile
April 23, 2019
Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. The deal is expected to close by the end of April.
Masy BioServices Acquires Metrology Laboratories contractpharma
April 09, 2019
Masy BioServices Acquires Metrology Laboratories
J&J completes acquisition of Auris Health biospectrumasia
April 04, 2019
Johnson & Johnson announced that its subsidiary Ethicon has completed the acquisition of Auris Health for approximately $3.4 billion in cash.
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre worldpharmanews
April 04, 2019
Novartis announced that it is adding to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre
Sterling Pharma Aquires CiVentiChem in the US contractpharma
April 03, 2019
Enhance chemistry development capabilities to support pre-clinical and early phase clinical supply
ResMed completes acquisition of HB Healthcare biospectrumasia
March 15, 2019
ResMed acquires HB Healthcare to help millions of Koreans living with sleep apnea, other respiratory conditions
BASi Appoints Key Executive contractpharma
March 08, 2019
Scott Daniels, PhD joins as senior vice president of DMPK, effective as of March 1, 2019
AGC Completes Acquisition of Spanish Synthetic Pharmaceutical Active Ingredient Manufacturer Malgrat Pharma Chemicals en-cphi.cn
March 07, 2019
AGC Inc. based in Tokyo announced on March 4 the completion of its acquisition of Spain's synthetic pharmaceutical active ingredient manufacturer, Malgrat Pharma Chemicals, S.L.U. (hereinafter referred to as MPC).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page